RADIOACTIVE DRUGS STRIKE CANCER WITH PRECISION

Summary from the TLDR newsletter

Radiation therapy has come a long way since X-ray therapy was born in 1896. Targeted radiopharmaceuticals helped the field achieve a new level of molecular precision. These agents deliver their radioactive payloads directly at tumor sites. While there are only a handful of these therapies commercially available for patients, the number is poised to grow as major players in the biopharmaceutical industry start to invest heavily in the technology.